The availability of critical medicines is under pressure within the European Union (EU) and globally. In recent years, shortages have become increasingly visible, partly because of geopolitical tensions and a heavy dependence on Asian countries for raw materials. To address this challenge, the Critical Medicines Alliance was established in April 2024 under the Belgian Presidency of the EU Council. This Alliance consists of stakeholders from healthcare, industry and civil society and works with representatives from European Member States to formulate sustainable solutions. The primary goal of the Alliance is to identify bottlenecks in the supply of medicines and formulate recommendations.
The result is impressive: the past year of intensive discussions with all stakeholders has led to the development of an ambitious strategic report. The report provides concrete recommendations to the European Commission, EU Member States and other stakeholders on how to strengthen the production of critical medicines within the EU and ensure strategic partnerships with non-EU countries.
news.belgium.be